More than half, 58%, said they are also positioned well to provide details on potential drug interactions, and 49% said they are able to give the patient the first injection as a demonstration
Patients who developed gastroparesis following pancreatitis episodes (while taking Ozempic or Wegovy) may have valid claims if they can establish the connection between their GLP-1 medication use and subsequent stomach paralysis diagnosis particularly when manufacturers failed to adequately warn patients about these risks
Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, et al
Human cytomegalovirus induces multiple means to combat reactive oxygen species
Study findings The risk of new-onset DR was slightly higher among GLP-1 RA users (hazard ratio 1.07, a 0.2% absolute increase over two years), but the incidence of NAION was numerically higher but not statistically significant in this group